Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot dual-partner antibiotic treatment for bacterial vaginosis
ACTRN12617001302347Phase 2Completed
- Sponsor
- Monash University
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of metronidazole and clindamycin in bacterial vaginosis (BV), sponsored by Monash University. Primary endpoint: Male participant acceptability and tolerability of treatment. Started Aug 2015; status: completed.
02
Drugs
metronidazoleclindamycin
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on ACTRN12617001302347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001302347.